Engineering principles for rationally design therapeutic strategies against hepatocellular carcinoma

被引:0
|
作者
Hernandez-Magana, Alexis [1 ]
Bensussen, Antonio [2 ]
Martinez-Garcia, Juan Carlos [2 ]
Alvarez-Buylla, Elena R. [1 ,3 ]
机构
[1] Univ Nacl Autonoma Mexico, Inst Biol, Mexico City, Mexico
[2] Cinvestav IPN, Dept Control Automat, Mexico City, Mexico
[3] Univ Nacl Autonoma Mexico, Ctr Ciencias Complej C3, Mexico City, Mexico
关键词
hepatocellular carcinoma; cancer; rational design; cell plasticity; medical systems biology; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-ASSOCIATED MACROPHAGES; FACTOR 4-ALPHA HNF4-ALPHA; CANCER STEM-CELLS; STELLATE CELLS; LIVER; PROMOTES; DEDIFFERENTIATION; TRANSCRIPTION; SENESCENCE;
D O I
10.3389/fmolb.2024.1404319
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The search for new therapeutic strategies against cancer has favored the emergence of rationally designed treatments. These treatments have focused on attacking cell plasticity mechanisms to block the transformation of epithelial cells into cancerous cells. The aim of these approaches was to control particularly lethal cancers such as hepatocellular carcinoma. However, they have not been able to control the progression of cancer for unknown reasons. Facing this scenario, emerging areas such as systems biology propose using engineering principles to design and optimize cancer treatments. Beyond the possibilities that this approach might offer, it is necessary to know whether its implementation at a clinical level is viable or not. Therefore, in this paper, we will review the engineering principles that could be applied to rationally design strategies against hepatocellular carcinoma, and discuss whether the necessary elements exist to implement them. In particular, we will emphasize whether these engineering principles could be applied to fight hepatocellular carcinoma.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinoma
    Yao, Min
    Yang, Jun-Ling
    Wang, De-Feng
    Wang, Li
    Chen, Ying
    Yao, Deng-Fu
    [J]. WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (11) : 3321 - 3333
  • [32] Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategies
    Wang, Nuozhou
    Wang, Shanshan
    Li, Ming-Yue
    Hu, Bao-guang
    Liu, Li-ping
    Yang, Sheng-li
    Yang, Shucai
    Gong, Zhongqin
    Lai, Paul B. S.
    Chen, George G.
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10
  • [33] Early diagnosis and therapeutic strategies for hepatocellular carcinoma: From bench to bedside
    Guan, Ming-Cheng
    Wang, Ming-Da
    Liu, Si-Yu
    Ouyang, Wei
    Liang, Lei
    Pawlik, Timothy M.
    Xu, Qiu-Ran
    Huang, Dong-Sheng
    Shen, Feng
    Zhu, Hong
    Yang, Tian
    [J]. WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 13 (04) : 197 - 215
  • [34] The immune microenvironment and progression of immunotherapy and combination therapeutic strategies for hepatocellular carcinoma
    Feng, Zun-Yong
    Xu, Fang-Gui
    Liu, Yu
    Xu, Hao-Jun
    Wu, Fu-Bing
    Chen, Xiao-Bing
    Xia, Hong-Ping
    [J]. HEPATOMA RESEARCH, 2021, 7
  • [35] Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinoma
    Min Yao
    Jun-Ling Yang
    De-Feng Wang
    Li Wang
    Ying Chen
    Deng-Fu Yao
    [J]. World Journal of Clinical Cases, 2022, 10 (11) : 3321 - 3333
  • [36] An Insight into the Novel Immunotherapy and Targeted Therapeutic Strategies for Hepatocellular Carcinoma and Cholangiocarcinoma
    Trifylli, Eleni-Myrto
    Koustas, Evangelos
    Papadopoulos, Nikolaos
    Sarantis, Panagiotis
    Aloizos, Georgios
    Damaskos, Christos
    Garmpis, Nikolaos
    Garmpi, Anna
    Karamouzis, Michalis V.
    [J]. LIFE-BASEL, 2022, 12 (05):
  • [37] Predisposition to Apoptosis in Hepatocellular Carcinoma: From Mechanistic Insights to Therapeutic Strategies
    Marquardt, Jens U.
    Edlich, Frank
    [J]. FRONTIERS IN ONCOLOGY, 2019, 9
  • [38] Therapeutic strategies for hepatitis B virus-associated hepatocellular carcinoma
    Wong, ET
    Chew, YP
    Lee, LA
    Lee, CGL
    [J]. CURRENT DRUG TARGETS, 2002, 3 (05) : 369 - 378
  • [39] Targeted polymeric therapeutic nanoparticles: Design and interactions with hepatocellular carcinoma
    Wang, Qi
    Sun, Ying
    Zhang, Zhirong
    Duan, Yourong
    [J]. BIOMATERIALS, 2015, 56 : 229 - 240
  • [40] Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma
    Wu, Xiong-Zhi
    Xie, Guang-Ru
    Chen, Dan
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (08) : 1178 - 1182